ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation

The excision repair cross-complementation group 1 (ERCC1) enzyme plays a rate-limiting role in the nucleotide excision repair pathway and is associated with resistance to platinum-based chemotherapy. The purpose of this study was to evaluate the role of ERCC1 expression as a predictive marker of sur...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jun, H J, Ahn, M J, Kim, H S, Yi, S Y, Han, J, Lee, S K, Ahn, Y C, Jeong, H-S, Son, Y-I, Baek, J-H, Park, K
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2008
Assuntos:
Molecular Diagnostics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2453006/
https://ncbi.nlm.nih.gov/pubmed/18594541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604464
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados